Value effectiveness analyses (CEA) purpose to look at how a brand new well being applied sciences impression well being outcomes and prices over a affected person’s lifetime. Whereas extrapolating long-run well being advantages and measuring potential price offsets are vital, one other vital merchandise to estimate is how the price of the brand new well being expertise is prone to evolve over occasions. That is notably related for prescribed drugs.
Whittington et al. (2024) write:
A drug’s internet worth typically will increase following launch and should later fall as opponents enter the market. Costs normally fall extra noticeably after the drug loses exclusivity and generic substitutes grow to be obtainable. Nevertheless, CEAs prior to now have hardly ever accounted for these prospects and as a substitute assume {that a} drug’s worth stays fixed over time.
Why is it vital to include dynamic pricing? FDA estimated that generic medication authorised in 2022 yielded $18.9 billion in whole financial savings in the course of the 12 months after their approvals.
…a CEA evaluating a brand new drug to a reasonable various can overstate the brand new drug’s added price over its life cycle if it assumes that the drug’s introductory worth will persist indefinitely. By neglecting to regulate for the “downstream” drop in worth, the CEA might incorrectly recommend the brand new drug represents unfavorable worth. Importantly, assumptions about drug worth dynamics also needs to apply to comparator therapies in an evaluation. Assuming no change in comparator drug costs can overstate the worth of the brand new drug if the comparator remedy is nearing its lack of market exclusivity. A static drug pricing assumption fails to account for anticipated financial savings from the genericization of the choice remedy…
Nonetheless, 95 % of revealed CEAs, together with these carried out by ICER, assume that drug costs stay fixed of their base case.
The necessity for dynamic pricing is especially vital when evaluating pharmaceutical to non-pharmaceutical well being applied sciences.
…omitting anticipated worth declines could make a drug look no extra enticing than an equally efficient non-drug intervention (for instance, surgical procedure) with the identical preliminary worth, despite the fact that worth declines following lack of exclusivity imply that the drug (not like the surgical procedure) will likely be cheaper over the long term.
The commentary continues by including that IRA has make the trajectory of drug pricing extra predictable as a result of (i) worth will increase are restricted to inflation and (ii) IRA permits CMS to barter chosen medication earlier than lack of exclusivity.
To learn the authors suggestions for incorporating dynamic pricing into CEA, you may learn the total article right here.
